抗利尿激素不适当综合征临床诊治

摘要/Abstract

摘要：

低钠血症是临床最常见的电解质紊乱，并增加患者病死率。而抗利尿激素不适当综合征(SIADH)是临床表现低钠血症的主要原因之一，其基础病因复杂且多样化，临床表现与低钠血症的程度和病程明显相关。因此，及早识别和正确诊断该病可减少误诊并降低病死率。临床上需要对该部分患者予以及时准确的诊断并制定个体化的治疗方案，而抗利尿激素受体拮抗剂在该类疾病的治疗中具有广阔的应用前景。

关键词: 抗利尿激素不适当综合征, 抗利尿激素受体拮抗剂

Abstract:

Abstract：Hyponatremia，the most commonly encountered electrolyte abnormality in clinical practice，increases morbidity itself.As a main risk factor for hyponatremia，the syndrome of inappropriate antidiuretic hormone secretion has complicated and complex etiology.The resultant clinical manifestations are significantly associated with the severity and duration of hyponatremia.Accordingly，its early detection and right diagnosis can decrease misdiagnosis and eventually mortality.Clinically，timely and correct diagnosis as well as individualized treatment plan is desired for such patients.Vasopressin receptor antagonists，anticipated as a more effective method to treat hyponatremia herald the beginning of a new era in the management of syndrome of inappropriate antidiuretic hormone disorders.

Key words: syndrome of inappropriate antidiuretic hormone secretion, vasopressin receptor antagonist

中图分类号:

R589.4

岑晶，顾锋. 抗利尿激素不适当综合征临床诊治[J]. 中国实用内科杂志.

CEN Jing,GU Feng.. Advances in the diagnosis and treatment of syndrome of inappropriate antidiuretic hormone secretion.[J]. Acta Metallurgica Sinica.

参考文献



［1］Elhassan EA，Schrier RW.Hyponatremia：diagnosis，complications，and management including V2 receptor antagonists［J］.Curr Opin Nephrol Hypertens，2011，20(2)：161-168. 

［2］Upadhyay A，Jaber BL，Madias NE.Epidemiology of hyponatremia［J］.Semin Nephrol，2009，29(3)：227-238. 

［3］Ellison DH，Berl T.The syndrome of inappropriate antidiuresis［J］.N Engl J Med，2007，356(20)：2064-2072. 

［4］Guy Decaux M.The Syndrome of Inappropriate Secretion of Antidiuretic Hormone (SIADH)［J］.Seminars in Nephrology，2009，29(3)：239-256. 

［5］许岭翎，顾锋，李梅，等.抗利尿不适当综合征40例临床特征分析［J］.中国实用内科杂志，2009，11(29)：1015-1017. 

［6］陈适，顾锋，张力，等.初诊时表现为低钠血症的肺癌27例临床特点分析［J］.中国实用内科杂志，2010，9(30)：803-804. 

［7］Decaux G，Vandergheynst F，Bouko Y，et al.Nephrogenic Syndrome of Inappropriate Antidiuresis in Adults：High Phenotypic Variability in Men and Women from a Large Pedigree［J］.Journal of the American Society of Nephrology，2007，18(2)：606-612. 

［8］Soule S，Florkowski C，Potter H，et al.Intermittent severe，symptomatic hyponatraemia due to the nephrogenic syndrome of inappropriate antidiuresis［J］.Ann Clin Biochem，2008，45(5)：520-523. 

［9］Nemerovski C，Hutchinson DJ.Treatment of hypervolemic or euvolemic hyponatremia associated with heart failure，cirrhosis，or the syndrome of inappropriate antidiuretic hormone with tolvaptan：A clinical review［J］.Clinical Therapeutics，2010，32(6)：1015-1032. 

［10］Mark Sherlock CJT.The syndrome of inappropriate antidiuretic hormone：current and future management options［J］.European Journal of Endocrinology，2010，162：S13-S18. 

［11］Esposito P，Piotti G，Bianzina S，et al.The Syndrome of Inappropriate Antidiuresis：Pathophysiology，Clinical Management and New Therapeutic Options［J］.Nephron Clin Pract，2011，119(1)：c62-c73. 

［12］Velez JC，Dopson SJ，Sanders DS，et al.Intravenous conivaptan for the treatment of hyponatraemia caused by the syndrome of inappropriate secretion of antidiuretic hormone in hospitalized patients：a single-centre experience［J］.Nephrol Dial Transplant，2010，25(5)：1524-1531. 

［13］Berl T，Quittnat-Pelletier F，Verbalis JG，et al.Oral tolvaptan is safe and effective in chronic hyponatremia［J］.J Am Soc Nephrol，2010，21(4)：705-712. 